Ian W. Campbell, Ph.D.
Affiliations: | 2011 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Russian history; Central Asian history; disaster history;Google:
"Ian Campbell"Parents
Sign in to add mentor| Douglas Taylor Northrop | grad student | 2011 | University of Michigan | |
| (Knowledge and Power on the Kazakh Steppe, 1845--1917.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Stolarova L, Kleiblova P, Zemankova P, et al. (2023) ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF14 |
| Lao C, Gurney J, Stanley J, et al. (2022) Association of diabetes and breast cancer characteristics at diagnosis. Cancer Causes & Control : Ccc |
| DeVries AA, Dennis J, Tyrer JP, et al. (2022) Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. Journal of the National Cancer Institute |
| Hakkaart C, Pearson JF, Marquart L, et al. (2022) Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology. 5: 1061 |
| Lao C, Mondal M, Kuper-Hommel M, et al. (2022) What affects the public healthcare costs of breast cancer in New Zealand? Asia-Pacific Journal of Clinical Oncology |
| Scott OW, Tin Tin S, Elwood JM, et al. (2022) Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study. Breast Cancer Research and Treatment |
| Lao C, Mondal M, Kuper-Hommel M, et al. (2022) Differences in Breast Cancer Costs by Cancer Stage and Biomarker Subtype in New Zealand. Pharmacoeconomics - Open |
| Dareng EO, Tyrer JP, Barnes DR, et al. (2022) Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg |
| Lao C, Kuper-Hommel M, Campbell I, et al. (2021) Use and results of systemic treatments for de novo and recurrent metastatic breast cancer: a population-based cohort study. The New Zealand Medical Journal. 134: 47-59 |
| Barnes DR, Silvestri V, Leslie G, et al. (2021) Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. Journal of the National Cancer Institute |